The importance of IGRA in patients candidates for biological therapy

Journal of Crohn's and Colitis

Volumn 7, Issue 11, 2013, Pages 928-929

  Cotter, José ^a   Rosa, Bruno ^a  

^a Gastroenterology Department of Centro Hospitalar do Alto Ave ^*  (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

BIOLOGICAL THERAPY; COHORT ANALYSIS; CONSENSUS; DRUG DOSE REGIMEN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LETTER; MEDICAL HISTORY; MEDICAL SOCIETY; MEDICATION COMPLIANCE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY ANALYSIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; TUBERCULOSIS;

EID: 84884819847     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.013     Document Type: Letter

References (5)

1. Jauregui-Amezaga A., Turon F., Ordas I., Gallego M., Feu F., Ricart E., et al. Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. J Crohns Colitis 2013, 7:208-212.
2. Duarte R., Campainha S., Cotter J., Rosa B., Varela P., Correia A., et al. Position paper on tuberculosis screening in patients with immune mediated inflammatory diseases candidates for biological therapy. Acta Reumatol Port 2012, 37:259.
3. Vassilopoulos D., Stamoulis N., Hadziyannis E., Archimandritis A.J. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J Rheumatol 2008, 35:1271-1276.
4. Solovic I., Sester M., Gomez-Reino J.J., Rieder H.L., Ehlers S., Milburn H.J., et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 2010, 36:1185-1206.
5. Leung C.C., Rieder H.L., Lange C., Yew W.W. Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 2011, 37:690-711.